"ACADIA plans to initiate a 12-week Phase 3 double-blind, randomized, placebo-controlled studyevaluating trofinetide in the second half of 2019 following completion of additional manufacturing scaleup activities."
"ACADIA plans to initiate a 12-week Phase 3 double-blind,...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.69 |
Change
0.030(0.24%) |
Mkt cap ! $1.730B | |||
| Open | High | Low | Value | Volume |
| $12.63 | $12.79 | $12.58 | $572.5K | 45.22K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 285 | $12.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.70 | 65 | 1 |
View Market Depth
| Last trade - 10.20am 26/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
